The 8-hour MOUD Training - PART 1 - 4/22/2024-Presentation Slides

Presentation Slides - Part 1 with Dr. Morrone

Pdf Summary

The document on PCSS Medications for Opioid Use Disorder (MOUD) Training introduces Dr. William Morrone's qualifications and the funding source. It addresses addiction as a chronic disorder and discusses factors contributing to substance use disorders. The negative impacts on healthcare, importance of evidence-based treatment, and effectiveness of medications like methadone, buprenorphine, and naltrexone are emphasized.<br /><br />Information on the pharmacology and usage of these medications is presented, stressing the need for thorough patient evaluation. Building a positive relationship with patients, using non-stigmatizing language, and providing ongoing support are highlighted. A case study of a university student with opioid use disorder is included, recommending medication-assisted treatment (MAT) with buprenorphine/naloxone, aiming to reduce cravings, manage withdrawal, and prevent relapse.<br /><br />The treatment plan involves individualized care with a focus on achieving and maintaining abstinence, improving academic performance, and addressing mental health issues. The initial prescription of buprenorphine/naloxone is suggested to be lower (2mg/0.5mg) for better monitoring and support initially. The overall approach involves a combination of medication, counseling, and support strategies tailored to the patient's needs to promote recovery and well-being.

Keywords

PCSS Medications for Opioid Use Disorder Training

Dr. William Morrone qualifications

Funding source

Addiction as chronic disorder

Substance use disorders factors

Medications: methadone, buprenorphine, naltrexone

Pharmacology of medications

Patient evaluation importance

Medication-assisted treatment (MAT)

Individualized care for opioid use disorder